2026 dyslipidemia guideliness

Created using ChatSlide

The 2026 Dyslipidaemia Guidelines offer a comprehensive update from the 2018 version, reflecting the latest research and consensus in lipid management. Authored by a multi-disciplinary team, the guidelines focus on evaluation and management, with new patient classification categories. Key updates include the introduction of PREVENT equations for ASCVD risk assessment, reestablishment of LDL-C and non-HDL-C goals, and recommendations for ApoB and Lp(a) testing. Clinicians are guided through...